Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Until today this year the stock’s price performance recorded a decrease of -52.86%. The price of BBNX decreased -29.45% over the last 30 days. And in the last five days, it has surged by 4.21%.
52-week price history of BBNX Stock
Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. Beta Bionics Inc’s current trading price is -54.53% away from its 52-week high, while its distance from the 52-week low is 25.31%. The stock’s price range during this time has been between $8.89 and $24.50. The trading volume for the Healthcare sector company’s shares reached about 0.42 million for the day, which was lower than the average daily volume of 0.62 million over the last three months.
Combining Moving Average and Trading Volume Data for Better Market Insight
BBNX’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for BBNX stands at 0.10. Similarly, the long-term debt-to-equity ratio is also 0.08.
BBNX Stock Stochastic Average
Today’s raw stochastic average for Beta Bionics Inc over the last 50 days is 14.55%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 32.85%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 26.89% and 23.62%, respectively.